Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography

PurposeThe utility of 18F-FDG PET/CT in the assessment of thyroid nodules is unclear as there are several conflicting reports on the usefulness of SUV as an indicator to distinguish benign from malignant thyroid lesions. This study incorporated an additional parameter, namely dual time point imaging, to determine the diagnostic accuracy of PET/CT imaging. The performance of 18F-FDG PET/CT was compared to that of high-resolution ultrasound which is routinely used for the evaluation of thyroid nodules.MethodsTwo hundred patients with incidentally detected solitary thyroid nodules were included in the study. Each patient underwent ultrasound and PET/CT evaluation within 7 days of each other, reported by an experienced radiologist and nuclear medicine specialist, respectively, in a blinded manner. The PET/CT criteria employed were maximum SUV (SUVmax) at 60 min and change in SUVmax at delayed (120 min) imaging. Final diagnosis was based on pathological evaluation and follow-up.ResultsOf the 200 patients, 26 had malignant and 174 had benign nodules. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of ultrasound were 80.8, 81.6, 39.6, 96.6 and 81.5%, respectively. Using SUVmax at 60 min as the diagnostic criterion, the above indices were 80.8, 84.5, 43.8, 96.7 and 84%, respectively, for PET/CT. The SUVmax of malignant thyroid lesions was significantly higher than benign lesions (16.2 ± 10.6 vs. 4.5 ± 3.1, respectively; p = 0.0001). Incorporation of percentage change in SUVmax at delayed imaging as the diagnostic criterion yielded a slightly improved sensitivity, specificity, PPV, NPV and accuracy of 84.6, 85.6, 46.8, 97.4 and 85.5%, respectively. There was a significant difference in percentage change in SUVmax between malignant and benign thyroid lesions (14.9 ± 11.4 vs. −1.6 ± 13.7, respectively; p = 0.0001). However, there was no statistically significant difference (95% confidence interval) between the diagnostic performance of PET/CT and ultrasound.ConclusionsRoutine use of 18F-FDG PET/CT with SUVmax at 60 min as the sole diagnostic criterion does not appear to have a significant advantage over high-resolution ultrasound in the evaluation of thyroid nodules. Incorporation of dual time point imaging enhances image interpretation, and yields a higher diagnostic performance, yet it is not statistically significant. Bearing in mind the cost, limited availability and radiation exposure, routine use of 18F-FDG PET/CT for distinguishing benign from malignant thyroid nodules cannot be recommended.

[1]  A. Miyauchi,et al.  Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. , 2007, Thyroid : official journal of the American Thyroid Association.

[2]  P. Walfish,et al.  Ultrasound-guided fine-needle aspiration biopsy in the management of thyroid disease. , 1993, American journal of surgery.

[3]  H. Gharib,et al.  Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. , 2000, Endocrinology and metabolism clinics of North America.

[4]  A. Alavi,et al.  Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  W. Oyen,et al.  18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  H. Gharib,et al.  Thyroid nodules: clinical importance, assessment, and treatment. , 2007, Endocrinology and metabolism clinics of North America.

[7]  V. Lowe,et al.  The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CT , 2007, Nuclear medicine communications.

[8]  D. Ross Nonpalpable thyroid nodules--managing an epidemic. , 2002, The Journal of clinical endocrinology and metabolism.

[9]  Dong Ik Kim,et al.  New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. , 2002, AJR. American journal of roentgenology.

[10]  Helen H. Wang,et al.  Reporting thyroid fine‐needle aspiration: Literature review and a proposal , 2006, Diagnostic cytopathology.

[11]  H. Stettner,et al.  Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. , 2003, Surgery.

[12]  R. Jeffrey,et al.  Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. , 2005, Ultrasound quarterly.

[13]  Jeong Hyun Lee,et al.  Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. , 2008, Radiology.

[14]  J. Boey,et al.  False-negative errors in fine-needle aspiration biopsy of dominant thyroid nodules: A prospective follow-up study , 1986, World Journal of Surgery.

[15]  A. Scarsbrook,et al.  Incidental thyroid nodule , 2009, BMJ : British Medical Journal.

[16]  Kyung-Han Lee,et al.  Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Jung-Hyun Yang,et al.  Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. , 2004, Thyroid : official journal of the American Thyroid Association.

[18]  A. Pontecorvi,et al.  Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. , 1998, Thyroid : official journal of the American Thyroid Association.

[19]  T. Aitman,et al.  Comparison of fine needle aspiration cytology, radioisotopic and ultrasound scanning in the management of thyroid nodules. , 1990, Postgraduate medical journal.

[20]  M. Yun,et al.  Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation. , 2008, AJR. American journal of roentgenology.

[21]  Tae Yong Kim,et al.  18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. , 2007, The Journal of clinical endocrinology and metabolism.

[22]  Terry S Desser,et al.  Common and Uncommon Sonographic Features of Papillary Thyroid Carcinoma , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[23]  L. Crapo,et al.  The epidemiology of thyroid disease and implications for screening. , 1997, Endocrinology and metabolism clinics of North America.

[24]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[25]  Gerard M Doherty,et al.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.

[26]  X. Lan,et al.  The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. , 2008, Clinical radiology.

[27]  S. Larson,et al.  FDG-PET Detected Thyroid Incidentalomas: Need for Further Investigation? , 2006, Annals of Surgical Oncology.

[28]  P. Hasselgren,et al.  Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. , 2005, Surgery.

[29]  Lin Li,et al.  Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions , 2009, Skeletal Radiology.

[30]  L. H. Nóbrega,et al.  Predicting malignant involvement in a thyroid nodule: role of ultrasonography. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[31]  J. Serpell,et al.  Management of the solitary thyroid nodule. , 2008, The oncologist.

[32]  Dong Gyu Na,et al.  Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. , 2008, Thyroid : official journal of the American Thyroid Association.

[33]  A. Miyauchi,et al.  Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy. , 1995, Thyroid : official journal of the American Thyroid Association.

[34]  M. Cohen,et al.  Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. , 2001, Surgery.

[35]  Yen-Ling Chen,et al.  Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. , 2005, Anticancer research.

[36]  Y. Oertel Fine-needle aspiration of the thyroid: technique and terminology. , 2007, Endocrinology and metabolism clinics of North America.

[37]  L. Adler,et al.  Positron emission tomography of thyroid masses. , 1993, Thyroid : official journal of the American Thyroid Association.

[38]  Seung-Yong Jeong,et al.  Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[39]  S. Parangi,et al.  The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. , 2005, Seminars in ultrasound, CT, and MR.

[40]  Tae Yong Kim,et al.  18F‐Fluorodeoxyglucose Uptake in Thyroid from Positron Emission Tomogram (PET) for Evaluation in Cancer Patients: High Prevalence of Malignancy in Thyroid PET Incidentaloma , 2005, The Laryngoscope.

[41]  S. Mandel What are the ultrasound criteria for fine-needle aspiration cytology of nonpalpable thyroid nodules? , 2006, Nature Clinical Practice Endocrinology &Metabolism.